Biohit Oyj (HEL:BIOBV)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostic Kits / Equipment	15.73M	14.28M	13.08M	10.95M	9.36M
Diagnostic Kits / Equipment Growth	10.14%	9.23%	19.40%	16.99%	31.42%
Total	15.73M	14.28M	13.08M	10.95M	9.36M
Total Growth	10.14%	9.23%	19.40%	16.99%	31.42%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Finland	248.00K	207.00K	211.00K	235.00K	238.00K
Finland Growth	19.81%	-1.90%	-10.21%	-1.26%	-14.08%
Europe, Other	5.55M	5.74M	5.70M	4.59M	4.29M
Europe, Other Growth	-3.29%	0.75%	24.16%	7.12%	17.75%
North and South America	353.00K	300.00K	324.00K	274.00K	282.00K
North and South America Growth	17.67%	-7.41%	18.25%	-2.84%	48.42%
Asia	6.89M	5.17M	4.57M	4.73M	3.61M
Asia Growth	33.11%	13.32%	-3.51%	30.91%	48.79%
Other Countries	2.69M	2.86M	2.28M	1.12M	941.00K
Other Countries Growth	-5.91%	25.66%	103.03%	19.13%	60.31%
Total	15.73M	14.28M	13.08M	10.95M	9.36M
Total Growth	10.14%	9.23%	19.39%	17.00%	31.42%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 24, 2026

Data Sources Report a data error